Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders
Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials
Jeff Conn named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics
Study explores potential new class of antidepressants